Stem cell treatments maker Mesoblast’s shares have taken a hit after the company said its $US50 million partnership with biotech giant Novartis has fizzled out.
Brisbane Times – Business
Business
More in:Business
Business
ABC’s departing boss finds himself in the last place he wanted to be
Managing director David Anderson’s farewell tour has taken an unlikely direction. Business / Workplace Brisbane ...
Business
‘Don’t mess with DOGE’: Musk uses X as weapon in cost-cutting crusade
As Elon Musk slashes US government spending, he has a tool no aspiring cost-cutter has ...
Business
Whitebark $2m placement fuels SA hydrogen-helium exploration
Whitebark Energy surged 25pc to 1c after a $2m placement to fuel a push into ...